Tiziana Life Sciences (TLSA) Other Non-Current Assets (2018 - 2020)
Tiziana Life Sciences (TLSA) posted quarterly Other Non-Current Assets of $269447.9 for Q2 2020, down 3.47% year-over-year from $279129.8 in Q3 2019, and down 3.42% quarter-over-quarter from $279002.3 in Q4 2019.
Tiziana Life Sciences (TLSA) Other Non-Current Assets (2018 - 2020) Analysis & Trends
Tiziana Life Sciences' Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $269447.9 for Q2 2020.
- In Q2 2020, Other Non-Current Assets fell 3.47% year-over-year to $269447.9; the TTM figure through Jun 2020 stood at $269447.9 (down 3.47% YoY), while the FY2019 annual figure was $285000.0, down 1.66% from the prior year.
- Other Non-Current Assets for Q2 2020 stood at $269447.9, down from $279002.3 in the prior quarter.
- The five-year high for Other Non-Current Assets was $295631.0 in Q2 2018, with the low at $269447.9 in Q2 2020.
- The 3-year median for Other Non-Current Assets is $279129.8 (2019), against an average of $280487.9.
- Peak annual rise in Other Non-Current Assets reached 0.08% in 2019, while the deepest fall reached 5.58% in 2019.
- Tiziana Life Sciences' Other Non-Current Assets stood at $279228.5 in 2018, then slipped by 0.08% to $279002.3 in 2019, then fell by 3.42% to $269447.9 in 2020.
- Business Quant data shows TLSA's Other Non-Current Assets at $269447.9 in Q2 2020, $279002.3 in Q4 2019, and $279129.8 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 269,447.94 |
| Dec 31, 2019 | 279,002.30 |
| Jun 30, 2019 | 279,129.84 |
| Dec 31, 2018 | 279,228.49 |
| Jun 30, 2018 | 295,631.00 |